Inventor · disambiguated record
Timothy Chan
Also filed as: CHAN TIMOTHY · CHAN TIMOTHY R · CHAN TIMOTHY RAYMOND
18 granted patents·8 pending applications·125 citations·filing 2007–2024
93Inventor score
Files withBIOGEN MA INC13SUNESIS PHARMACEUTICALS INC5VIRACTA THERAPEUTICS INC4BIOGEN IDEC INC2ARNDT JOSEPH1
Top patents by PatentIndex Score
26 records- 0191US10081619B2Biaryl inhibitors of bruton's tyrosine kinaseBIOGEN MA INC·Filed 2017·Granted Sep 25, 2018·7 cites·4 claims
- 0291US9944622B2Pyrimidinyl tyrosine kinase inhibitorsBIOGEN MA INC·Filed 2016·Granted Apr 17, 2018·8 cites·16 claims
- 0391US9809577B2Biaryl inhibitors of Bruton's tyrosine kinaseBIOGEN MA INC·Filed 2014·Granted Nov 7, 2017·12 cites·2 claims
- 0491US9353087B2Inhibitors of Bruton's tyrosine kinaseBIOGEN IDEC INC·Filed 2013·Granted May 31, 2016·8 cites·19 claims
- 0591US8293923B2Indazole derivatives as modulators of interleukin-1 receptor-associated kinaseGUCKIAN KEVIN·Filed 2007·Granted Oct 23, 2012·52 cites·27 claims
- 0690US10759783B2Biaryl inhibitors of Bruton'S tyrosine kinaseBIOGEN MA INC·Filed 2018·Granted Sep 1, 2020·3 cites·11 claims
- 0789US9394277B2Pyrimidinyl tyrosine kinase inhibitorsBIOGEN IDEC INC·Filed 2013·Granted Jul 19, 2016·11 cites·26 claims
- 0888US9771326B2S1P and/or ATX modulating agentsBIOGEN MA INC·Filed 2013·Granted Sep 26, 2017·6 cites·11 claims
- 0984US10618887B2Pyrimidinyl tyrosine kinase inhibitorsSUNESIS PHARMACEUTICALS INC·Filed 2018·Granted Apr 14, 2020·3 cites·17 claims
- 1084US9850206B2S1P and/or ATX modulating agentsBIOGEN MA INC·Filed 2013·Granted Dec 26, 2017·4 cites·22 claims
- 1184US2024294524A1Heterocyclic compounds useful as pdk1 inhibitorsVIRACTA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1283US2024417389A1Pyrimidinyl tyrosine kinase inhibitorsVIRACTA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1382US10246456B2IRAK4 inhibiting agentsBIOGEN MA INC·Filed 2015·Granted Apr 2, 2019·5 cites·4 claims
- 1480US10030016B2Heterocyclic compounds useful as PDK1 inhibitorsSUNESIS PHARMACEUTICALS INC·Filed 2015·Granted Jul 24, 2018·2 cites·16 claims
- 1577US2023113598A1Heterocyclic compounds useful as pdk1 inhibitorsVIRACTA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1677US2023174511A1Pyrimidinyl tyrosine kinase inhibitorsVIRACTA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1773US10577367B2IRAK4 inhibiting agentsBIOGEN MA INC·Filed 2019·Granted Mar 3, 2020·1 cites·6 claims
- 1870US9546165B2Heterocyclic compounds useful as PDK1 inhibitorsARNDT JOSEPH·Filed 2010·Granted Jan 17, 2017·2 cites·12 claims
- 1970US2021070752A1Heterocyclic compounds useful as pdk1 inhibitorsSUNESIS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2068US11572356B2Biaryl inhibitors of Bruton's tyrosine kinaseBIOGEN MA INC·Filed 2020·Granted Feb 7, 2023·0 cites·17 claims
- 2168US2021017155A1Pyrimidinyl tyrosine kinase inhibitorsSUNESIS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2266US10280169B2Biaryl bruton's tyrosine kinase inhibitorsBIOGEN MA INC·Filed 2014·Granted May 7, 2019·1 cites·16 claims
- 2363US10189817B2Inhibitors of Bruton's tyrosine kinaseBIOGEN MA INC·Filed 2018·Granted Jan 29, 2019·0 cites·6 claims
- 2463US2019119268A1Heterocyclic compounds useful as pdk1 inhibitorsSUNESIS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2554US2017114039A1Inhibitors of bruton's tyrosine kinaseBIOGEN MA INC·Filed 2016·Application pending·0 cites
- 2642US11427561B2IRAK4 inhibiting agentsBIOGEN MA INC·Filed 2017·Granted Aug 30, 2022·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Timothy Chan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →